Skip to main content
. Author manuscript; available in PMC: 2014 Mar 16.
Published in final edited form as: J Proteome Res. 2010 Feb 5;9(2):865–875. doi: 10.1021/pr900761m

Figure 6. Comparison of calbinding-D28 among treatment groups using Western blot analysis.

Figure 6

Analysis of variance: p= 0.00015. Significance levels *: *:p<0.05; **: p<0.001; (Tukey method). β-Actin was used as control and was expected not to change. Abbreviations: CsA10: 10 mg/kg/d cyclosporine, CsA10+Srl1: 10 mg/kg/d cyclosporine+ 1 mg/kg/d sirolimus, Srl1: 1 mg/kg/d sirolimus, Tac1: 1 mg/kg/d tacrolimus, Tac1+Srl1: 1 mg/kg/d tacrolimus + 1 mg/kg/d sirolimus.